Skip to main content
Premium Trial:

Request an Annual Quote

Ambry Named Roche NimbleGen Service Provider

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ambry Genetics has become a certified service provider for the Roche NimbleGen SeqCap EZ Exome workflow, the firms announced today.

Aliso Viejo, Calif.-based Ambry will provide target enrichment services using SeqCap EZ Human Exome combined with next-generation sequencing services.

The SeqCap EZ Exome technology uses a single tube of stable DNA oligos to capture all exons in solution in a simple, scalable workflow, and contains 2.1 million empirically optimized DNA probes, according to Roche NimbleGen.

Under the partnership, Ambry will process customers' genomic DNA samples for enrichment using SeqCap to capture all human coding exons, and sequence the enriched samples using short-read, paired-end sequencing. According to the firms, Ambry is Roche NimbleGen's first service provider in the US offering the SeqCap EZ Human Exome product.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.